Explore the role of preclinical MRI in studying neurological diseases, with a focus on advanced cellular and molecular ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the ...

Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Robeauté’s microrobots can enter the brain to diagnose, treat and monitor neurological conditions in a way that was ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

Theranexus has announced the publication of its letter to shareholders, highlighting its ongoing efforts in developing treatments for rare neurological disorders. This communication demonstrates ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

Immunotherapeutic approaches that target the adaptive and innate immune systems are being explored for the treatment of almost all neurological diseases, and the targets and approaches are often ...

Despite the advances in antibiotic treatments, ear infections can still lead to severe neurological complications such as ...

Researchers from the University of Glasgow are set to lead a £4m new project to investigate the potential of ‘neurobots’ to treat epilepsy.